First Tracks Biotherapeutics (TRAX) — Financial Flexibility Index
First Tracks Biotherapeutics (TRAX) has a Financial Flexibility Index of -2.49x as of December 2024. Free cash flow of $-125.45 Million (operating CF $-125.81 Million minus capex $358.00K) represents -2% of total liabilities ($50.30 Million). Also explore net asset momentum of First Tracks Biotherapeutics to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
First Tracks Biotherapeutics Financial Flexibility Index (2023–2024)
Historical Financial Flexibility Index trend for First Tracks Biotherapeutics across 2 annual periods. Check First Tracks Biotherapeutics PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for First Tracks Biotherapeutics (2023–2024)
Year-by-year free cash flow to debt coverage for First Tracks Biotherapeutics. For the full company profile including market capitalisation, see First Tracks Biotherapeutics (TRAX) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.49x | $-125.45 Million | $-125.81 Million | $50.30 Million | ▲ +7.3% |
| 2023 | -2.69x | $-92.20 Million | $-93.00 Million | $34.26 Million | — |